Anisa Gopalani, MD
Pain Medicine · Huntsville, TXNPI 1174535033
Payments from drug & device makers
Across 536 payments — averaging $64.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$10K
- Si-bone, Inc.$9K
- Surgentec$9K
- Boston Scientific$1K
- AbbVie$1K
- Spinal Simplicity, LLC$699
- plus $4K from 31 others
What the payments were for
- Consulting fees$12,17535%
- Travel & lodging$6,58819%
- Food & beverage$15,89646%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 286 | $9,753 |
| Si-bone, Inc. | 17 | $9,348 |
| Surgentec | 3 | $8,638 |
| Boston Scientific | 31 | $1,179 |
| AbbVie(2 entities) | 57 | $1,078 |
| Spinal Simplicity, LLC | 9 | $699 |
| Medtronic | 10 | $584 |
| Vertos Medical, Inc. | 15 | $543 |
| MDD US Operations, LLC | 7 | $464 |
| Pacira Therapeutics, Inc. | 20 | $340 |
| Relievant Medsystems, Inc. | 4 | $217 |
| MML US, Inc. | 2 | $192 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $180 |
| Nalu Medical, Inc. | 8 | $156 |
| Vertiflex, Inc. | 11 | $148 |
| Forte Bio-pharma LLC | 1 | $125 |
| Saluda Medical Americas, Inc. | 2 | $117 |
| Collegium Pharmaceutical, Inc. | 7 | $115 |
| Organogenesis Inc. | 1 | $108 |
| Biodelivery Sciences International, Inc. | 5 | $63 |
| Biohaven Pharmaceuticals, Inc. | 3 | $59 |
| Biotronik NRO, Inc. | 2 | $59 |
| Curonix LLC | 3 | $55 |
| Pfizer | 3 | $53 |
| Stryker | 2 | $50 |
| Painteq LLC | 2 | $44 |
| GRT US Holding, Inc. | 1 | $42 |
| Tersera Therapeutics LLC | 2 | $40 |
| Teva Pharmaceuticals USA, Inc. | 2 | $31 |
| SPR Therapeutics, Inc | 1 | $28 |
| Merz North America, Inc. | 1 | $27 |
| Stimwave Technologies Incorporated | 1 | $27 |
| Vertex | 1 | $24 |
| Novartis | 1 | $19 |
| Bioventus LLC | 1 | $19 |
| Nevro Corp. | 1 | $19 |
| Amgen | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TiLink$8,638
- IFUSE IMPLANT SYSTEM$8,508
- ION Facet Screw System$5,713
- PROCLAIM$3,866
- Proclaim IPG$1,128
- Proclaim Family of SCS IPGs$539
- Prolate$500
- HA MINUTEMAN G3-R$370
- MYOBLOC$351
- Intracept$279
- ETERNA$274
- VERCISE$234
- V-LOC 180$202
- ReActiv8$185
- Axium Sheath Braided DRG$143
- Nalocet$125
- QULIPTA$124
- UBRELVY$124
- WaveWriter Alpha Prime 16$121
- SUPERION$120
How this compares
$34,659 in reported general payments places this provider in the 90th percentile of 583 pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| UbrelvyUbrogepant | 27 | $41,902 |
| BelbucaBuprenorphine Hcl | 33 | $25,191 |
| NucyntaTapentadol Hcl | 22 | $23,349 |
| QuliptaAtogepant | 19 | $19,707 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 962 | $18,979 |
| Fentanyl | 83 | $9,443 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 174 | $5,525 |
| MovantikNaloxegol Oxalate | 13 | $5,397 |
| Buprenorphine | 19 | $3,476 |
| Gabapentin | 337 | $3,246 |
| Oxycodone Hcl | 109 | $2,718 |
| Pregabalin | 126 | $2,442 |
| Morphine Sulfate ErMorphine Sulfate | 73 | $2,021 |
| Tramadol Hcl ErTramadol Hcl | 22 | $1,714 |
| Morphine Sulfate | 70 | $1,560 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieUbrelvy, Qulipta | $1,078 | $61,61046 claims |
| Collegium Pharmaceutical, Inc.Belbuca, Nucynta | $115 | $48,54155 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 583 pain medicine providers in Texas.
Other pain medicine in Huntsville
- Aaron CalodneyTyler$3M
- Mitchell EngleHouston$1.5M
- Melissa MurphyGrapevine$711K
- Shiraz YazdaniLubbock$632K
- Muhammad ZulqarnainDallas$556K
- Daniel PakHouston$460K
- Marvin ChangSugar Land$306K
- David LeimanHouston$281K
- Candice BurnetteSugar Land$265K
- Ellen LinSan Antonio$251K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.